Test Price
2,000 AED✅ Home Collection Available
Insulin Antibodies Highly Sensitive Test – 2000 AED – UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (Available daily 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Compliant with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Test Overview & Methodology
This highly sensitive radioimmunoassay (RIA) measures circulating insulin autoantibodies to aid in the diagnosis of autoimmune diabetes and monitoring of insulin therapy. It is a pivotal tool for differentiating Type 1 diabetes from other forms and assessing risk in first‑degree relatives.
Comparison with Closest Alternative
| Feature | Our Test (Insulin Ab RIA) | Alternative (Insulin Ab ELISA) |
|---|---|---|
| Methodology | Radioimmunoassay (RIA) | Enzyme‑Linked Immunosorbent Assay |
| Sensitivity | >99% | ~85% |
| Turnaround Time | 2–3 weeks (specimen received by 7th of month) | 5–7 days |
| Sample Volume | 2 mL serum (red‑top tube) | 1 mL serum |
| Cost | 2000 AED | ~1500 AED |
Physician Insight & Safety Protocols
Note from Dr. Ajay Singh (DHA: 36234132): “As a General Practitioner with extensive experience in autoimmune diagnostics, I emphasize that this test is a cornerstone for identifying autoimmune diabetes. Results must always be interpreted alongside clinical symptoms, glucose profiles, and C‑peptide levels. Never rely on this test in isolation—it is part of a comprehensive metabolic and immunological evaluation.”
Medication Advisory
⚠️ Important Medication Advisory
Do not discontinue prescribed insulin or oral hypoglycaemic agents without prior consultation with your treating physician. Abrupt discontinuation can precipitate severe hyperglycaemia or diabetic ketoacidosis. This test does not replace regular therapeutic monitoring.
Safety Exclusions & ER Red Flags
Exclusion Criteria
- Hemolyzed or lipemic serum.
- Sample collected in SST gel barrier tubes (only red‑top permitted).
- Serum not separated from clot within 1 hour of collection.
- Missing mandatory signed consent (Form FP‑M‑01).
Emergency Department Red Flags
- Signs of diabetic ketoacidosis (vomiting, confusion, fruity breath).
- Severe hypoglycaemia (loss of consciousness, seizure).
- Extreme hyperglycaemia (blood glucose >600 mg/dL) with ketones.
- Immediately seek emergency care; do not wait for test results.
Safety governed by Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. What is the clinical utility of the Insulin Antibodies Highly Sensitive test?
This test detects insulin autoantibodies to diagnose autoimmune diabetes (Type 1), guide insulin therapy decisions, and predict disease risk in first‑degree relatives. Positive results strongly support autoimmune etiology, while negative results do not fully exclude it, especially in adults.
2. What are the sample collection requirements?
You need to provide a red‑top tube (no gel) serum sample that must be separated within one hour of collection. The mandatory consent form (FP‑M‑01) must be signed. VIP home phlebotomy is available daily from 8 AM to 11 PM.
3. When should I expect my results?
Results are reported 2–3 weeks after the laboratory receives your sample. For batch processing, samples must arrive by the 7th of the month to be included in the next cycle.
4. Who should consider this test?
Individuals with new‑onset diabetes of uncertain type, those with atypical features (e.g., older age at diagnosis without metabolic syndrome), first‑degree relatives of Type 1 patients, and patients with suspected latent autoimmune diabetes in adults (LADA).
5. Can this test be performed during pregnancy?
Yes, but only if clinically indicated. The test does not pose direct risk, but insulin autoantibodies cross the placenta. Discuss with your obstetrician before proceeding.
UAE Regulatory & Data Privacy Adherence
Your data is protected under:
- Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) – governs collection, storage, and sharing of your health information.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – ensures secure electronic health records and telemedicine compliance.
- Federal Decree‑Law No. 4 of 2016 on Medical Liability – establishes your rights regarding medical error and informed consent.
Results are encrypted, access‑logged, and never shared with third parties without your explicit written consent.
Clinical & Logistical Metadata
| Test Name | Insulin Antibodies Highly Sensitive (RIA) |
| Price (AED) | 2,000 AED |
| Turnaround Time | 2–3 weeks (sample must arrive by the 7th of the month) |
| Sample Type / Matrix | Serum (red‑top tube, no gel separator) |
| Methodology Used | Radioimmunoassay (RIA) |
| ICD-10-CM Code | E10.8 (Type 1 diabetes mellitus with other specified complications), E10.9 (without complications), E08.0, E08.8 |
| LOINC Code | 3417-8 (Insulin Ab [Presence] in Serum) |
| DHA Facility License & Address | License 1143 | DNA Labs UAE | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians